Related Experiment Video

Updated: Jul 25, 2025

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

9.0K

Editorial: Heterogeneity and plasticity of prostate cancer

Zoran Culig1, Mohit Kumar Jolly2, Karel Souček3,4

  • 1Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.

Frontiers in Molecular Biosciences
|June 30, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
heterogeneityimmunotherapyoncogenic miRNAplasticityprostate cancertherapy resistancetranscription factorstumor-suppressive miRNA

More Related Videos

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.7K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

715

Related Experiment Videos

Last Updated: Jul 25, 2025

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

9.0K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.7K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

715

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K

Articles linked to this work by shared authors, journal, and citation graph.

Phenotypic memory of hypoxic exposure duration drives tumor invasion dynamics.

Biophysical journal·2026

Interplay Between Immune Checkpoint Modulators and the Epithelial-to-Mesenchymal Transition Axis in Clear Cell Renal Cell Carcinoma.

Cancers·2026

Varying susceptibility of subpopulations along the epithelial-mesenchymal spectrum to undergo EMT.

The FEBS journal·2026

Distinct geometrical landscapes distinguish between modes of tristability in gene regulatory networks.

Journal of the Royal Society, Interface·2026

TGF-β-producing tBregs are associated with poor survival rates in PTGS2-high cancers.

Cell death & disease·2026

Systems-level analysis identifies IRF6 as an inhibitor of epithelial-mesenchymal transition.

Journal of biological engineering·2026

Nanozymes for extracellular matrix and cell sheet engineering: biomedical potential and complementary enzymatic strategies.

Frontiers in molecular biosciences·2026

Novel GLA variant (c.752A>C; p.Glu251Ala) identified in a patient with Fabry cardiomyopathy and familial segregation.

Frontiers in molecular biosciences·2026

Lactylation in sepsis-associated acute kidney injury: regulatory mechanisms and therapeutic prospects.

Frontiers in molecular biosciences·2026

Targeting ferroptosis and mitochondrial ROS: organoprotective mechanisms of anesthetic conditioning in liver transplantation.

Frontiers in molecular biosciences·2026

Functional characterisation of PREL-1 and PREL-3 proteins as putative intramitochondrial phospholipid transporters governing homeostasis and organismal health in Caenorhabditis elegans.

Frontiers in molecular biosciences·2026

MicroRNA signatures in inflammatory dental tissues: biomarkers and molecular mechanisms.

Frontiers in molecular biosciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us